La psilocibina si profila come un potenziale catalizzatore nel trattamento del Disturbo Ossessivo-Compulsivo refrattario. Analizziamo criticamente i dati di un recente trial clinico per capire come questa molecola possa creare una 'finestra di opportunità' per sbloccare i meccanismi cognitivi su cui la CBT lavora da sempre.
Argomenti:
PsicoterapiaPsichedelica, DisturboOssessivoCompulsivo, CBT, Psilocibina, TerapiaCognitivoComportamental, RicercaClinica, DOCRefrattario
📖 Fonte (ipsico.it):
https://ipsico.it/news/psichedelici-e-disturbo-ossessivo-compulsivo-evidenze-empiriche-e-prospettive-cliniche/
Bibliografia:
📖 American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing.
Bogenschutz, M. P., et al. (2022). Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry.
Carhart-Harris, R. L., et al. (2021). Trial of Psilocybin versus Escitalopram for Depression. New England Journal of Medicine, 384(15), 1402–1411.
Davis, A. K., et al. (2020). Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA psychiatry.
Goodwin, G. M., et al. (2023). Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life. Journal of affective disorders, 327, 120-127.
Kelmendi, B., et al. (in press). Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial. https://doi.org/10.31234/osf.io/atfum_v1
Luoma, J. B., et al. (2020). A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy. Journal of Psychoactive Drugs, 52(4), 289–299.
Mitchell, J. M., et al. (2023). MDMA-assisted therapy for moderate to severe PTSD: A randomized, placebo-controlled phase 3 trial. Nature Medicine, 29(10), 2473–2480.
Pittenger, C., & Bloch, M. H. (2014). Pharmacological treatment of obsessive-compulsive disorder. Psychiatr Clin North Am, 37, 375-391.
Skapinakis, P., et al. (2016). Pharmacological and psychotherapeutic interventions for management of obsessive compulsive disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry, 3, 730-739.
Stein, D. J., et al. (2019). Obsessive-compulsive disorder. Nat Rev Dis Primers, 5, 52.
----
A cura del dott. Carmine D'Anzica, Psicologo e Psicoterapeuta